120 related articles for article (PubMed ID: 33276040)
1. The predictive power of CD3
Spanier G; Ugele I; Nieberle F; Symeou L; Schmidhofer S; Brand A; Meier J; Spoerl S; Krupar R; Rümmele P; Siska P; Renner K; Peter K; Gerken M; Beckhove P; Reichert TE; Kreutz M; Singer K
Cancer Lett; 2021 Feb; 499():209-219. PubMed ID: 33276040
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
Zhou C; Diao P; Wu Y; Wei Z; Jiang L; Zhang W; Li Z; Ye J; Song X; Wu H; Jiang H; Wang Y; Cheng J
Int J Cancer; 2020 Feb; 146(4):1152-1163. PubMed ID: 31304591
[TBL] [Abstract][Full Text] [Related]
3. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts.
Jensen DH; Therkildsen MH; Dabelsteen E
J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
Takahashi H; Sakakura K; Arisaka Y; Tokue A; Kaira K; Tada H; Higuchi T; Okamoto A; Tsushima Y; Chikamatsu K
Anticancer Res; 2019 Jun; 39(6):3039-3046. PubMed ID: 31177146
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma.
Hatano K; Saigo C; Kito Y; Shibata T; Takeuchi T
Clin Exp Dent Res; 2020 Apr; 6(2):174-180. PubMed ID: 32250571
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
8. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
10. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
12. Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
Mukherjee G; Bag S; Chakraborty P; Dey D; Roy S; Jain P; Roy P; Soong R; Majumder PP; Dutt S
PLoS One; 2020; 15(11):e0242058. PubMed ID: 33211709
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
14. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
15. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
[TBL] [Abstract][Full Text] [Related]
18. Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor.
Singer K; Kastenberger M; Gottfried E; Hammerschmied CG; Büttner M; Aigner M; Seliger B; Walter B; Schlösser H; Hartmann A; Andreesen R; Mackensen A; Kreutz M
Int J Cancer; 2011 May; 128(9):2085-95. PubMed ID: 20607826
[TBL] [Abstract][Full Text] [Related]
19. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Liu Y; Li R; Ren G
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
[TBL] [Abstract][Full Text] [Related]
20. Relationship between p16 expression and prognosis in different anatomic subsites of OSCC.
Ni Y; Zhang X; Wan Y; Dun Tang K; Xiao Y; Jing Y; Song Y; Huang X; Punyadeera C; Hu Q
Cancer Biomark; 2019; 26(3):375-383. PubMed ID: 31594213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
